Cargando…
Extracellular Vesicles Derived From Ex Vivo Expanded Regulatory T Cells Modulate In Vitro and In Vivo Inflammation
Extracellular vehicles (EVs) are efficient biomarkers of disease and participate in disease pathogenesis; however, their use as clinical therapies to modify disease outcomes remains to be determined. Cell-based immune therapies, including regulatory T cells (Tregs), are currently being clinically ev...
Autores principales: | Thome, Aaron D., Thonhoff, Jason R., Zhao, Weihua, Faridar, Alireza, Wang, Jinghong, Beers, David R., Appel, Stanley H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258040/ https://www.ncbi.nlm.nih.gov/pubmed/35812435 http://dx.doi.org/10.3389/fimmu.2022.875825 |
Ejemplares similares
-
Ex vivo expansion of dysfunctional regulatory T lymphocytes restores suppressive function in Parkinson’s disease
por: Thome, Aaron D., et al.
Publicado: (2021) -
Restoring regulatory T-cell dysfunction in Alzheimer’s disease through ex vivo expansion
por: Faridar, Alireza, et al.
Publicado: (2020) -
Ex vivo expanded human regulatory T cells modify neuroinflammation in a preclinical model of Alzheimer’s disease
por: Faridar, Alireza, et al.
Publicado: (2022) -
Elevated acute phase proteins reflect peripheral inflammation and disease severity in patients with amyotrophic lateral sclerosis
por: Beers, David R., et al.
Publicado: (2020) -
Serum programmed cell death proteins in amyotrophic lateral sclerosis
por: Beers, David R., et al.
Publicado: (2021)